Loading...
•
Sep 30, 2022
CareDx Q3 2022 Earnings Report
Achieved revenue growth and made progress towards profitable growth with positive adjusted EBITDA by the first half of 2023.
Key Takeaways
CareDx reported a 5% year-over-year increase in revenue, reaching $79.4 million for the third quarter of 2022. The company is on track to achieve profitable growth with positive adjusted EBITDA by the first half of 2023.
On track to achieve profitable growth with positive adjusted EBITDA by first half of 2023
Delivered 46,500 patient test results, representing growth of 15% compared to third quarter of 2021
Achieved revenue of $79.4 million, increasing 5% year-over-year
Sustained strong testing services GAAP gross margin of 73% and non-GAAP gross margin of 74%
Revenue by Segment
Forward Guidance
CareDx is revising revenue expectations to be in the range of $320 million to $325 million for the full year 2022.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...